Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1987 Oct;46(10):757–762. doi: 10.1136/ard.46.10.757

Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.

K Berglund 1, C Keller 1, H Thysell 1
PMCID: PMC1003383  PMID: 3500678

Abstract

Fourteen consecutive patients with chronic inflammatory rheumatic disease and reactive renal amyloidosis were treated with alkylating cytostatics in 22 separate periods varying in duration between six and 30 months. Chlorambucil alone was given in 14 treatment periods, cyclophosphamide alone in six, and both alternately in two. The dosage was adjusted to attain a major suppression of the rheumatic inflammation and a blood lymphocyte level below 1.0 X 10(9)/l. Renal function improved in 12 treatment periods, renal deterioration was arrested in three periods, and in another four periods the rate of functional decline slowed down. In the remaining three treatment periods, associated with further deterioration in renal function, treatment was inadequate owing to blood dyscrasia and failure to control hypertension. Glomerular filtration rate (GFR) was followed more closely in 10 treatment periods, in all of which the falling trend was arrested or reduced. The survival rate at five years was 93%. Three patients who dropped out of the treatment programme are so far the only ones not still alive. Nine are still being followed up after 6-17 years, and the other two remaining live patients have had renal transplants for five years.

Full text

PDF
757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berglund K., Laurell A. B., Nived O., Sjoholm A. G., Sturfelt G. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation. J Clin Lab Immunol. 1980 Jul;4(1):7–14. [PubMed] [Google Scholar]
  2. Castor C. W., Bull F. E. Review of United States data on neoplasms in rheumatoid arthritis. Am J Med. 1985 Jan 21;78(1A):33–38. doi: 10.1016/0002-9343(85)90243-8. [DOI] [PubMed] [Google Scholar]
  3. Clive D. M., Stoff J. S. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984 Mar 1;310(9):563–572. doi: 10.1056/NEJM198403013100905. [DOI] [PubMed] [Google Scholar]
  4. Dikman S. H., Kahn T., Gribetz D., Churg J. Resolution of renal amyloidosis. Am J Med. 1977 Sep;63(3):430–433. doi: 10.1016/0002-9343(77)90281-9. [DOI] [PubMed] [Google Scholar]
  5. Falck H. M., Törnroth T., Skrifvars B., Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand. 1979;205(7):651–656. doi: 10.1111/j.0954-6820.1979.tb06121.x. [DOI] [PubMed] [Google Scholar]
  6. Fausa O., Nygaard K., Elgjo K. Amyloidosis and Crohn's disease. Scand J Gastroenterol. 1977;12(6):657–662. doi: 10.3109/00365527709181699. [DOI] [PubMed] [Google Scholar]
  7. Glenner G. G. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980 Jun 12;302(24):1333–1343. doi: 10.1056/NEJM198006123022403. [DOI] [PubMed] [Google Scholar]
  8. Hazleman B. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Am J Med. 1985 Jan 21;78(1A):39–43. doi: 10.1016/0002-9343(85)90244-x. [DOI] [PubMed] [Google Scholar]
  9. Jacquot C., d'Auzac C., Loirat P., Bariety J. Aggravation foudroyante d'amylose rénale après chirurgie. Trois observations. Nouv Presse Med. 1981 Nov 14;10(41):3389-90, 3395. [PubMed] [Google Scholar]
  10. Kinlen L. J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med. 1985 Jan 21;78(1A):44–49. doi: 10.1016/0002-9343(85)90245-1. [DOI] [PubMed] [Google Scholar]
  11. Kisilevsky R. Amyloidosis: a familiar problem in the light of current pathogenetic developments. Lab Invest. 1983 Oct;49(4):381–390. [PubMed] [Google Scholar]
  12. Schnitzer T. J., Ansell B. M. Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum. 1977 Mar;20(2 Suppl):245–252. [PubMed] [Google Scholar]
  13. Wright J. R., Calkins E. Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 1981 Nov;60(6):429–448. doi: 10.1097/00005792-198111000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES